Christian Chabannon

ORCID: 0000-0002-3755-4889 · 3 papers in corpus
review 1995
A review of 76 patients with myelodysplastic syndromes treated with danazol
·doi:10.1002/1097-0142(19950101)75:1<133::aid-cncr2820750124>3.0.co;2-i
review 1994
A review of 76 patients with myelodysplastic syndromes treated with danazol
·doi:10.1002/1097-0142(19940615)73:12<3073::aid-cncr2820731228>3.0.co;2-#

BACKGROUND: Treatment of myelodysplastic syndromes (MDSs) remains unsatisfactory. A limited number of reports provide contradictory information on whether danazol, a synthetic androgen, may be useful in patients with MDS. METHODS: Between 1…

article 1990
Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia.

We report the positive effect of danazol on clinical and hematological data in a patient with myelofibrosis and myeloid metaplasia. Severe cytopenia was corrected within 2 months and was maintained for an additional 2-month period. Myeloid …